Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Parallel-group, Placebo-controlled, Safety-assessor Blinded Trial in Adult Subjects Evaluating the Efficacy and Safety of Sugammadex for Reversal of Pipecuronium-induced Neuromuscular Blockade in Subjects Undergoing Abdominal Surgery Under General Anesthesia

NCT01424488 is registered in ClinicalTrials.gov with Central Clinical Hospital #1 of LLC Russian Railways as lead sponsor.

NCT NCT01424488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01424488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Parallel-group, Placebo-controlled, Safety-assessor Blinded Trial in Adult Subjects Evaluating the Efficacy and Safety of Sugammadex for Reversal of Pipecuronium-induced Neuromuscular Blockade in Subjects Undergoing Abdominal Surgery Under General Anesthesia
Lead sponsor
Central Clinical Hospital #1 of LLC Russian Railways
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
February 29, 2012
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult subjects undergoing abdominal surgery under general anesthesia